185 related articles for article (PubMed ID: 15360020)
1. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib.
Heartin E; Walkinshaw S; Clark RE
Leuk Lymphoma; 2004 Jun; 45(6):1307-8. PubMed ID: 15360020
[No Abstract] [Full Text] [Related]
2. Pregnancy outcome of two patients treated with imatinib.
Prabhash K; Sastry PS; Biswas G; Bakshi A; Prasad N; Menon H; Parikh PM
Ann Oncol; 2005 Dec; 16(12):1983-4. PubMed ID: 16100234
[No Abstract] [Full Text] [Related]
3. Pregnancy in patients with chronic myeloid leukemia treated with imatinib.
Yilmaz M; Demirhan O; Kuçukosmanoglu E; Pehlivan M; Okan V; Balat O; Pehlivan S
Leuk Lymphoma; 2007 Dec; 48(12):2454-6. PubMed ID: 18067024
[No Abstract] [Full Text] [Related]
4. Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.
Skoumalova I; Vondrakova J; Rohon P; Rozmanova S; Jarosova M; Indrak K; Prochazka M; Santava A; Faber E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):121-3. PubMed ID: 18795086
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia. Sceptical scientists.
Druker BJ
Lancet; 2001 Dec; 358 Suppl():S11. PubMed ID: 11784560
[No Abstract] [Full Text] [Related]
6. Twin pregnancy in a patient of chronic myeloid leukemia on imatinib therapy.
Meera V; Jijina F; Shrikande M; Madkaikar M; Ghosh K
Leuk Res; 2008 Oct; 32(10):1620-2. PubMed ID: 18420270
[TBL] [Abstract][Full Text] [Related]
7. Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester.
Suppiah R; Kalaycio M
Leuk Lymphoma; 2006 Jun; 47(6):1149-50. PubMed ID: 16840209
[No Abstract] [Full Text] [Related]
8. Imatinib mesylate in the treatment of chronic myeloid leukaemia.
Druker BJ
Expert Opin Pharmacother; 2003 Jun; 4(6):963-71. PubMed ID: 12783592
[TBL] [Abstract][Full Text] [Related]
9. Complete cytogenetic and molecular response to treatment with imatinib mesylate for philadelphia chromosome positive acute myeloid leukemia with multilineage dysplasia.
Ueda K; Horiike S; Zen K; Misawa S; Taniwaki M
Leuk Lymphoma; 2006 Sep; 47(9):1967-9. PubMed ID: 17065015
[No Abstract] [Full Text] [Related]
10. Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response.
Kuwabara A; Babb A; Ibrahim A; Milojkovic D; Apperley J; Bua M; Reid A; Foroni L; Rezvani K; Goldman J; Marin D
Blood; 2010 Aug; 116(6):1014-6. PubMed ID: 20705771
[No Abstract] [Full Text] [Related]
11. Imatinib mesylate.
Am J Health Syst Pharm; 2001 Dec; 58(23):2241-2. PubMed ID: 11765724
[No Abstract] [Full Text] [Related]
12. Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib.
Tsuzuki M; Inaguma Y; Handa K; Hasegawa A; Yamamoto Y; Watanabe M; Mizuta S; Maruyama F; Okamoto M; Emi N
Intern Med; 2009; 48(16):1433-5. PubMed ID: 19687593
[TBL] [Abstract][Full Text] [Related]
13. 3. Imatinib therapy in chronic myelogenous leukemia.
Jinnai I
Intern Med; 2007; 46(2):95-7. PubMed ID: 17220607
[No Abstract] [Full Text] [Related]
14. Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?
White DL
Leuk Lymphoma; 2008 Jun; 49(6):1022-3. PubMed ID: 18452091
[No Abstract] [Full Text] [Related]
15. Pregnancy on imatinib: fatal outcome with meningocele.
Choudhary DR; Mishra P; Kumar R; Mahapatra M; Choudhry VP
Ann Oncol; 2006 Jan; 17(1):178-9. PubMed ID: 16291579
[No Abstract] [Full Text] [Related]
16. Issues of imatinib and pregnancy outcome.
Apperley J
J Natl Compr Canc Netw; 2009 Nov; 7(10):1050-8. PubMed ID: 19930974
[TBL] [Abstract][Full Text] [Related]
17. [Treatment for de novo chronic myeloid leukemia in chronic phase].
Hirase C; Matsumura I
Nihon Rinsho; 2012 Apr; 70 Suppl 2():298-303. PubMed ID: 23133971
[No Abstract] [Full Text] [Related]
18. Persistence of molecular remission throughout pregnancy in CML after imatinib.
Sorà F; De Matteis S; Bajer J; D'alò F; Leone G; Sica S
Leuk Res; 2009 Jun; 33(6):e6-7. PubMed ID: 18937976
[No Abstract] [Full Text] [Related]
19. David A. Karnofsky Award lecture. Imatinib as a paradigm of targeted therapies.
Druker BJ
J Clin Oncol; 2003 Dec; 21(23 Suppl):239s-245s. PubMed ID: 14645403
[No Abstract] [Full Text] [Related]
20. Concomitant myelodysplastic syndrome and chronic myeloid leukaemia: treatment outcomes with imatinib mesylate.
Mesa RA; Steensma DP; Hoyer J; Ketterling RP
Br J Haematol; 2003 Oct; 123(2):366-7. PubMed ID: 14531922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
